FENC

Fennec Pharmaceuticals Inc. - Common Stock (FENC)

About Fennec Pharmaceuticals Inc. - Common Stock (FENC)

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Details

Daily high

$10.95

Daily low

$10.27

Price at open

$10.68

52 Week High

$13.25

52 Week Low

$5.65

Market cap

379.8M

Dividend yield

Volume

228,388

Avg. volume

143,534

P/E ratio

-84.54

Fennec Pharmaceuticals Inc. - Common Stock News